Mechanisms of vascular permeability and remodeling associated with hemarthrosis in factor VIII-deficient mice

被引:13
|
作者
Cooke, Esther J. [1 ,2 ]
Wyseure, Tine [2 ]
Zhou, Jenny Y. [1 ]
Gopal, Srila [1 ]
Nasamran, Chanond A. [3 ]
Fisch, Kathleen M. [3 ]
Manon-Jensen, Tina [4 ]
Karsdal, Morten A. [4 ]
Mosnier, Laurent O. [2 ]
von Drygalski, Annette [1 ,2 ]
机构
[1] Univ Calif San Diego, Div Hematol Oncol, Dept Med, La Jolla, CA 92121 USA
[2] Scripps Res Inst, Dept Mol Med, La Jolla, CA USA
[3] Univ Calif San Diego, Ctr Computat Biol & Bioinformat, La Jolla, CA 92121 USA
[4] Nordic Biosci Biomarker & Res, Herlev, Denmark
基金
美国国家卫生研究院;
关键词
factor VIII; hemarthrosis; hemostasis; sequence analysis; RNA; vascular remodeling; POWER DOPPLER SONOGRAPHY; HEMOPHILIC SYNOVITIS; MURINE MODEL; TENASCIN-C; TISSUE; JOINT; ANGIOGENESIS; ARTHROPATHY; MIGRATION; TURNOVER;
D O I
10.1111/jth.14567
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Vascular remodeling associated with hemophilic arthropathy (HA) may contribute to bleed propagation, but the mechanisms remain poorly understood. Objectives To explore molecular mechanisms of HA and the effects of hemostasis correction on synovial vascular remodeling after joint injury in hypocoagulable mice. Methods Factor VIII (FVIII)-deficient mice +/- FVIII treatment and hypocoagulable wild-type mice ((Hypo)BALB/c) were subjected to subpatellar puncture. (Hypo)BALB/c mice were treated with warfarin and anti-FVIII before injury, after which warfarin was continued for 2 weeks or reversed +/- continuous anti-FVIII until harvest. Synovial vascularity was analyzed at baseline and 2 to 4 weeks post injury by histology, musculoskeletal ultrasound with power Doppler (microvascular flow), and Evans blue extravasation (vascular permeability). Synovial gene expression and systemic markers of vascular collagen turnover were studied in FVIII-deficient mice by RNA sequencing and enzyme-linked immunosorbent assay. Results Vascular changes occurred in FVIII-deficient and (Hypo)BALB/c mice after injury with minimal effect of hemostasis correction. Increased vascular permeability was only significant in FVIII-deficient mice, who exhibited more pronounced vascular remodeling than (Hypo)BALB/c mice despite similar bleed volumes. FVIII-deficient mice exhibited a strong transcriptional response in synovium that was only partially affected by FVIII treatment and involved genes relating to angiogenesis and extracellular matrix remodeling, with vascular collagen turnover markers detected systemically. Conclusions Intact hemostasis at the time of hemarthrosis and during healing are both critical to prevent vascular remodeling, which appears worse with severe and prolonged FVIII deficiency. Unbiased RNA sequencing revealed potential targets for intervention and biomarker development to improve management of HA.
引用
收藏
页码:1815 / 1826
页数:12
相关论文
共 50 条
  • [21] Can we prevent inhibitors in mild and moderate factor VIII-deficient patients?
    Aledort, LM
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (04) : 914 - 914
  • [22] Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice
    VandenDriessche, T
    Vanslembrouck, V
    Goovaerts, I
    Zwinnen, H
    Vanderhaeghen, ML
    Collen, D
    Chuah, MKL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) : 10379 - 10384
  • [23] Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women
    Mannucci, PM
    BLOOD, 2005, 105 (08) : 3382 - 3382
  • [24] Long-term expression of human coagulation factor VIII and stable correction of hemophilia "A" after noninvasive retroviral gene transfer in factor VIII-deficient mice
    VandenDriessche, T
    Vanslembrouck, V
    Goovaerts, I
    Zwinnen, H
    Collen, D
    Chuah, MKL
    THROMBOSIS AND HAEMOSTASIS, 1999, : 30 - 30
  • [25] Naturally occurring CD4+ CD25+ cells in modulating immune response to administered coagulation factor VIII in factor VIII-deficient mice
    Kallas, A.
    Kuuse, S.
    Maimets, T.
    Pooga, M.
    HAEMOPHILIA, 2011, 17 (01) : 143 - 151
  • [26] Intra-articular injection of mesenchymal stem cells expressing coagulation factor ameliorates hemophilic arthropathy in factor VIII-deficient mice
    Kashiwakura, Y.
    Ohmori, T.
    Mimuro, J.
    Yasumoto, A.
    Ishiwata, A.
    Sakata, A.
    Madoiwa, S.
    Inoue, M.
    Hasegawa, M.
    Ozawa, K.
    Sakata, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (09) : 1802 - 1813
  • [27] Intra-articular injection of autologous mesenchymal stem cells ameliorates hemophilic arthropathy in factor VIII-deficient mice
    Kashiwakura, Y.
    Ohmori, T.
    Mimuro, J.
    Yasumoto, A.
    Ishiwata, A.
    Sakata, A.
    Madoiwa, S.
    Inoue, M.
    Hasegawa, M.
    Watanabe, N.
    Tatsumi, K.
    Ohashi, K.
    Okano, T.
    Sakata, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 232 - 233
  • [28] Emicizumab improves the stability and structure of fibrin clot derived from factor VIII-deficient plasma, similar to the addition of factor VIII
    Shimonishi, Naruto
    Nogami, Keiji
    Ogiwara, Kenichi
    Matsumoto, Tomoko
    Nakazawa, Fumie
    Soeda, Tetsuhiro
    Hirata, Michinori
    Arai, Nobuo
    Shima, Midori
    HAEMOPHILIA, 2020, 26 (03) : E97 - E105
  • [29] Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice
    Schaefer, ML
    Wong, ST
    Wozniak, DF
    Muglia, LM
    Liauw, JA
    Zhuo, M
    Nardi, A
    Hartman, RE
    Vogt, SK
    Luedke, CE
    Storm, DR
    Muglia, LJ
    JOURNAL OF NEUROSCIENCE, 2000, 20 (13): : 4809 - 4820
  • [30] Immune response to human factor VIII in factor VIII deficient mice.
    Qian, J
    Bi, L
    Kazazian, HH
    Hoyer, LW
    BLOOD, 1995, 86 (10) : 769 - 769